EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sea Urchin Pigment Ethylspinazarin (U-573): A Novel P2X7 Receptor Antagonist with Neuroprotective and Antiparkinsonian Effects

Evgeny Pislyagin iD, Sergey Kozlovskiy iD, Irina Agafonova iD, Ekaterina Menchinskaya, Ekaterina Chingizova iD, Tatiana Gorpenchenko iD, Anatolii Mirochnik, Elena Fedorenko, Yuri Sabutski iD, Sergei Polonik, Dmitry Aminin iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26178639 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Evgeny Pislyagin und 10 weiteren Autor:innen. Beteiligte Einrichtung: G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-Eastern Branch of the Russian Academy of Science, 690022 Vladivostok, Russia. Hauptthemen laut MEDLINE: Neuroprotective Agents, Receptors, Purinergic P2X7, Purinergic P2X Receptor Antagonists, Sea Urchins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Russian Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ability of the quinonoid sea urchin pigment ethylspinazarin (U-573) to protect mouse Neuro-2a neuronal cells from the neurotoxic effect of one of the Parkinson’s disease inducers, MPP+, was studied. This compound blocked Ca2+ influx and inhibited macropore formation through the P2X7 receptor induced by high concentrations of ATP. Ethylspinazarin at a concentration of 10 μM increased the viability of neuronal cells treated with the neurotoxin by approximately 15% and reduced the level of NO and ROS to control values. Further, U-573 prevented the MPP+-induced formation of amyloid-like protein aggregates in neuronal cells by approximately 50%. This compound at a dosage of 1 mg/kg exerted an anti-inflammatory effect in a mouse model of inflammation, reducing ATP-induced paw edema to values of intact animals. Moreover, the potential of ethylspinazarin in providing an antiparkinsonian effect was shown using a mouse model of MPTP-induced Parkinson’s disease. It is likely that the antiparkinsonian activity in in vivo experiments may be mediated by the ability of U-573 to cross the blood–brain barrier. Finally, we found that U-573 effectively inhibits the functioning of ATP-dependent purinergic P2X7 receptors in neuronal cells. This property may be of key importance in the manifestation of the antiparkinsonian activity of this 1,4-naphthoquinone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroprotective AgentsReceptors, Purinergic P2X7Purinergic P2X Receptor AntagonistsSea UrchinsAntiparkinson AgentsNaphthoquinonesAnimalsMiceAdenosine TriphosphateNeuronsDisease Models, AnimalMaleCell Survival

Stichwörter der Autor:innen

1,4-naphthoquinonesP2X7RParkinson’s diseaseneuronal cellsneuroprotection

Substanzen

Neuroprotective AgentsReceptors, Purinergic P2X7Purinergic P2X Receptor AntagonistsAntiparkinson AgentsNaphthoquinonesAdenosine Triphosphate

Autor:innen und Institutionen

  • G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-Eastern Branch of the Russian Academy of Science, 690022 Vladivostok, Russia.
  • Federal Scientific Center of East Asia Terrestrial Biodiversity, Far Eastern Branch of the Russian Academy of Sciences, 690022 Vladivostok, Russia.
  • Institute of Chemistry, Far Eastern Branch of the Russian Academy of Sciences, 690022 Vladivostok, Russia.
  • Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.

ORCID-Profile: Evgeny Pislyagin, Sergey Kozlovskiy, Irina Agafonova, Ekaterina Chingizova, Tatiana Gorpenchenko, Yuri Sabutski, Dmitry Aminin

Förderung

  • Russian Science Foundation
  • Russian Academy of Sciences

Zitieren

APA

Pislyagin, E., Kozlovskiy, S., Agafonova, I., Menchinskaya, E., Chingizova, E., Gorpenchenko, T., Mirochnik, A., Fedorenko, E., Sabutski, Y., Polonik, S., & Aminin, D. (2025). Sea Urchin Pigment Ethylspinazarin (U-573): A Novel P2X7 Receptor Antagonist with Neuroprotective and Antiparkinsonian Effects. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178639

Vancouver

Pislyagin E, Kozlovskiy S, Agafonova I, Menchinskaya E, Chingizova E, Gorpenchenko T, et al. Sea Urchin Pigment Ethylspinazarin (U-573): A Novel P2X7 Receptor Antagonist with Neuroprotective and Antiparkinsonian Effects. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178639

BibTeX
@article{Pislyagin2025,
  author = {Pislyagin, Evgeny and Kozlovskiy, Sergey and Agafonova, Irina and Menchinskaya, Ekaterina and Chingizova, Ekaterina and Gorpenchenko, Tatiana and Mirochnik, Anatolii and Fedorenko, Elena and Sabutski, Yuri and Polonik, Sergei and Aminin, Dmitry},
  title = {Sea Urchin Pigment Ethylspinazarin (U-573): A Novel P2X7 Receptor Antagonist with Neuroprotective and Antiparkinsonian Effects},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26178639}
}
Kostenlos starten →